- Previous Close
0.0095 - Open
0.0095 - Bid 0.0095 x --
- Ask 0.0415 x --
- Day's Range
0.0095 - 0.0095 - 52 Week Range
0.0070 - 0.0175 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
9.182M - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells home based maternity monitoring technology in Australia, United States of America, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Melbourne, Australia.
www.hera-med.comRecent News: 1I4.F
View MorePerformance Overview: 1I4.F
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1I4.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1I4.F
View MoreValuation Measures
Market Cap
9.09M
Enterprise Value
7.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
24.04
Price/Book (mrq)
5.20
Enterprise Value/Revenue
36.91
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-91.62%
Return on Equity (ttm)
-317.64%
Revenue (ttm)
364.33k
Net Income Avi to Common (ttm)
-5.49M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
3.17M
Total Debt/Equity (mrq)
2.96%
Levered Free Cash Flow (ttm)
-2.75M